Expression of cytokeratin among the selected cells, and the presence of cytokeratin+ aneuploid cells (>2N DNA content) among both CD90+ and EpCAM+ populations from all patients confirms the tumor origin of the cytokeratin+ and/or aneuploid subpopulations (Figures 1e and f). The gene discussed is THY1; the disease is neoplasm.